Chapter 3: 5-HT2c receptor modulators: Progress in development of new CNS medicines

Annual Reports in Medicinal Chemistry

Volumn 37, Issue , 2002, Pages 21-30

  Fitzgerald, Lawrence W ^a   Ennis, Michael D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038568057     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-7743(02)37004-0     Document Type: Article

References (88)

1. I.H Page Physiol. Rev. 34 1954 563
2. D.W Wooley E Shaw Proc. Natl. Acad. Sci., USA 40 1954 228
3. A Dahlström K Fuxe Acta. Psychiatr. Scand. 62 1964 1
4. L Uphouse Neurosci. & Behav. Rev. 21 1997 679
5. N.M Barnes T Sharp Neuropharmacology 38 1999 1083
6. P.R Hartig Molecular Biology and Transduction Characteristics of 5-HT Receptors Vol. 129 1997 Springer (7)
7. D Hoyer D.E Clarke J.R Fozard P.R Hartig G.R Martin E.J Mylecharane P.R Saxena P.P Humphrey Pharmacol. Rev. 46 1994 157
8. J.R Raymond Y.V Mukin A Gelasco J Turner G Collinsworth T.W Gettys J.S Grewal M.N Gamovskaya Pharmacol. & Ther. 92 2001 179
9. B.J Jones T.P Blackburn Pharmacol, Biochem. Behav. 71 2002 555
10. A.J Robichaud B.L Largent Annu. Rep. Med. Chem. 35 2000 11
11. L.M Gaster F.D King Annu. Rep. Med. Chem. 33 1998 21
12. M Isaac Drugs of the Future 26 2001 383
13. L Yu H Nguyen H Le L.J Bloem C.A Kozak B.J Hoffman T.P Snutch H.A Lester N Davidson H Lubbert Mol. Brain Res. 11 1991 143
14. H Canton R.B Emeson E.L Barker J.R Backstrom J.T Lu M.S Chang E Sanders-Bush Mol. Pharmacol. 50 1996 799
15. C.M Burns H Chu S.M Rueter L.K Hutchinson H Canton E SandersBush R.B Emeson Nature 387 1997 303
16. C.M Niswender S.C Copeland K Herick-Davis R.B Emeson E Sanders-Bush J. Biol. Chem. 274 1999 9472
17. L.W Fitzgerald G Iyer D.S Conklin C.M Krause A Marshall J.P Patterson D.P Tran G.J Jonak P.R Hartig Neuropsychopharmacology 21 1999 82S
18. R.D Price D.M Weiner M.S Chang E Sanders-Bush J. Biol. Chem. 276 2001 44663
19. A Pazos R Cortes J.M Palacios Brain Res. 346 1985 231
20. B.J Hoffmann E Mezey FEBS Left. 247 1987 453
21. J.F Lopez-Gimenez G Mengod J.M Palacios M.T Vilaro Synapse 42 2001 12
22. D.A Clemett T Punhani M.S Duxon T.P Blackburn K.C Kone Neuropharmacolology 39 2000 123
23. P.J Conn E Sander-Bush J. Pharmacol. Exp. Ther. 242 1987 552
24. L.W Fitzgerald D.S Conklin C.M Krause A.P Marshall J.P Patterson D.P Tran G Iyer W.A Kostich B.L Largent P.R Hartig J. Neurochem. 72 1999 2127
25. R.H.P Porter K.R Benwell H Lamb C.S Malcolm N.H Allen D.F Revell D.R Adams M.J Sheardown Brit. J. Pharamacol. 128 1999 13
26. J.C Jarman S.J Brough T Gager M Wood M.C Coldwell D Smart D.N Middlemiss Eur. J. Pharmacol. 414 2001 23
27. M.S Chang L Zhang J.P Tam E Sanders-Bush J. Biol. Chem. 275 2000 7021
28. C.C Felder R.Y Kanterman A.L Ma J Axelrod Proc. Natl. Acad. Sci. 87 1990 2187
29. K.A Berg S Maayani J Goldfarb C Scaramelli P Leff W.P Clarke Mol. Pharmacol. 54 1998 94
30. M Marcoli G Maura M Tortarolo M Raiteri J. Neurochem. 69 1997 427
31. V.L Lucaites D.L Nelson D.B Wainscott M Baez Life Sci. 59 1996 1081
32. C Becamel A Figge S Poliak A Dumuis E Peles J Bockaert H Lubbert C Ullmer J. Biol., Chem. 275 2001 12974
33. J.R Backstrom M.S Chang H Chu C.M Niswender E Sander-Bush J. Biol. Chem. 275 2000 23620
34. S.P Vickers M.J Bickerdike C.T Dourish Neurosci. News 2 1999 22
35. P.G Clifton M.D Lee C.T Dourish Psychopharmacology 152 2000 256
36. K.C.F Fone R.H Austin I.A Topham G.A Kennett T Punhani Brit. J. Pharmacol. 123 1998 1707
37. M.J Bickerdike S.P Vickers C.T Dourish Diabetes Obes. Metab. 1 1999 207
38. L.H Tecott L.M Sun S.F Akana A.M Strack D.H Lowenstein M.F Dallman D Julius Nature 374 1995 542
39. S.P Vickers G.A Kennett C.T Dourish L.H Tecott Psychopharmacology 143 1999 309
40. P.A Sargent A.L Sharpley C Williams E.M Goodall P.J Cowen Psychopharmacology 133 1997 309
41. G Curzon E.L Gibson A.O Oluyomi Trends Pharmacol. Sci. 18 1998 21
42. S.P Vickers C.T Dourish G.A Kennett Neuropharmacology 41 2001 200
43. L.W Fitzgerald T.C Burn B.S Brown J.P Patterson M.H Corjay P.A Valentine J.H Sun J.R Link I Abbaszade J.M Hollis B.L Largent P.R Hartig G.F Hollis P.C Meunier A.J Robichaud D.W Robertson Mol. Pharmacol. 57 2000 75
44. R.B Rothman M.H Baumann J.E Savage L Rauser A McBride S Hufisein B.L Roth Circulation 102 2000 2836
45. R.B Rothman M.H Baumann Pharmacol. Biochem. Behav. 71 2002 825
46. L.K Heisler H.M Chu L.H Tecott Ann. NY Acad., Sci. 861 1998 74
47. C.D Applegate L.H Tecott Exp. Neurol. 154 1998 522
48. N Upton T Stean D Middlemiss T Blackburn G Kennett Eur. J. Pharmacol. 359 1998 33
49. B.L Roth D Roland D Ciaranello H.Y Meltzer J. Pharmacol. Exp. Ther. 260 1992 1361
50. K Herrick-Davis E Grinde M Teitler J. Pharmacol. Exp. Ther. 295 2000 226
51. V Di Matteo M Cacchio C Di Giulio E Esposito Pharmacol. Biochem. Behav. 71 2002 727
52. A Deutch B Moghaddam R.B Innis J.H Krystal G.K Aghajanian B.S Bunney D.S Charney Schizophren. Res. 4 1991 121
53. J.R Martin T.M Ballard G.A Higgins Pharmacol. Biochem. Behav. 71 2002 615
54. M.D Wood C Reavill B Trail A Wilson T Steen G Kennet S Lighthowler T.P Blackburn D.T Thomas T.L Gager Neuropharmacology 41 2001 186
55. I Gacsályi E Schmidt I Gyertyán E Vaser A Lang A Fekete J Hietala E Syvälahti P Tuomainen P.T Männistö Drug Dev. Res. 40 1997 333
56. F Jenck J.L Moreau H Berendsen M Boas C.L.E Broekkamp J.R Martin J Wichmann A.M.L Van Delft Eur. Neuropsychopharmacol. 8 1998 161
57. J.R Martin M Bös F Jenck J.-L Moreau V Mutel A.J Sleight J Wichmann J.S Andrews H.H.G Berendsen C.L.E Broekkamp G.S.F Ruigt C Köhler A.M.L Van Delft J. Pharmacol. Exp. Ther. 286 1998 913
58. H Naukkararinen Eur. Neuropsychopharmacology 11 Suppl. 3 2001 S301
59. M Bos F Jenck J.R Martin J.-L Moreau A.J Sleight J Wichmann U Widmer J. Med. Chem. 40 1997 2762
60. J Chang-Fong J Addo M Dukat C Smith N.A Mitchell K Herrick-Davis M Teitler R.A Glennon Bioorg. Med. Chem. Lett. 12 2002 155
61. 61. (2000).
62. 62.
63. 63. Adams and N.J. Monck, WO Patent 0112603-A1 (2001).
64. 64. Davidson, M.J. Bickerdike, I.A. Cliffe and H.L. Mansell, WO Patent 0012510 (2000).
65. 65.
66. M Issac A Slassi A O'Brien L Edwards N MacLean D Bueschkens D.K Lee K McCallum I De Lannoy L Demchyshyn R Kamboj Bioorg. Med. Chem. Lett. 10 2000 919
67. 67.
68. R.B McCall S.R Franklin D.K Hyslop C.S Knauer C.L Chio C.L Haber L.W Fitzgerald Soc. Neurosci. Abst. 2001
69. 69. Bebbington, N.J. Monck, C.E. Dawson, R.M. Pratt and A.R. George, WO Patent 0012475 (2000).
70. 70. Cliffe, WO Patent 0012502 (2000).
71. 71. 0112602 A1 (2001).
72. 72. 0044753 (2000).
73. 73. Patent 0210169 A1 (2002).
74. 74.
75. 75. and D.M. Zawrotny, WO Patent 0077001 A1 (2000).
76. 76. McClung, E.J.B. Calvello and D.M. Zawrotny, WO Patent 0077002 A1 (2000).
77. 77. Calvello and D.M. Zawrotny, WO Patent 0077010 A2 (2000).
78. A.J Robichaud W Chen C McClung M Stranz D Clark W Deng E.B Calvello I.S Mitchell T Lee P Rajagopalan D.W Robertson B.F Molino S.N Haydar M.P Conlon B.C Duffy J Liao N.G Pawlush L.W Fitzgerald D.S Conklin C.M Krause J.F McElroy K.W Rohrbach K.J Miller B.L Largent Abstracts of Papers, MEDI-105, 221st ACS National Meeting San Diego, CA 2001
79. 79. (2001).
80. 80.
81. G.S Welmaker J.A Nelson J.E Sabalski A.L Sabb J.R Potoski D Graziano M Kagan J Coupet J Dunlop H Mazandarani S Rosenzweig-Lipson S Sukoff Y Zhang Bioorg. Med. Chem. Lett. 10 2000 1991
82. S.M Bromidge Abstracts of Papers, MEDI-304, 222nd ACS National Meeting Chicago, IL, United States, August 26–30 2001
83. M.D Wood C Reavill B Trail A Wilson T Steen G.A Kennett S Lightowler T.P Blackburn D Thomas T.L Gager G Riley V Holland S.M Bromidge I.T Forbes D.N Middlemiss Neuropharmacology 41 2001 186
84. M.I Smith D.C Piper M.S Duxon N Upton Pharmacol. Biochem. Behav. 71 2002 599
85. 85. (2002).
86. 86.
87. 87.
88. 88.